📚 PASS Investment Adviser (Level 1) Difficulty: Beginner ℹ️ Info   ~5 min read
📌 Chapter 6.1 — Nature and Definition of Primary Markets

Imagine you are an equity analyst covering a mid-cap manufacturing firm that has just announced a rights issue to fund a new production facility. As you update your valuation model, you notice the stock price dropping, yet the company is offering shares to existing shareholders at a discount. Your task is to distinguish between the dilution of earnings per share and the actual wealth transfer occurring through Rights Entitlements (REs).

Understanding whether to exercise, renounce, or let these rights lapse is critical for your clients’ portfolios, as it directly impacts their effective cost of acquisition and their proportional stake in the firm.

A rights issue functions as a capital-raising tool where current shareholders are given the preemptive privilege to buy additional shares at a specified price. Crucially, these ‘Rights Entitlements’ are often tradeable instruments on Indian stock exchanges. If an investor chooses not to participate in the capital increase, they can sell their REs on the market, thereby monetizing the ‘value’ of their preemptive right. This structure prevents the involuntary dilution of their economic interest, provided they are attentive enough to trade the entitlement before the closing date.

From a modeling perspective, the rights issue introduces a ‘dilution factor’ that you must account for in your Forward P/E calculations. Because the shares are issued at a discount, the market price of the stock typically adjusts downward on the ex-rights date to reflect the theoretical ex-rights price (TERP). Failing to incorporate this adjustment leads to an artificially high target price. You must calculate the weighted average of the pre-issue shares and the new discounted shares to accurately reflect the post-issue equity base.

Consider a firm offering one new share for every four held at a 20% discount. An investor holding 100 shares receives 25 REs. If the investor lacks the liquidity to subscribe, selling these 25 REs allows them to recoup the dilution loss, effectively keeping their total wealth neutral.

As an analyst, you are not just checking the company’s solvency; you are advising on whether the capital raise is ‘value-accretive’—meaning the return on the new assets financed by the rights issue should exceed the cost of equity. If the company’s internal rate of return on the expansion is lower than the cost of equity, the rights issue effectively destroys shareholder value, regardless of the share price discount.

Nuance

⚠️ Nuance
A common trap for candidates is the belief that a rights issue at a discount is inherently ‘cheap’ and therefore beneficial to the shareholder. In reality, the stock price adjusts downward on the ex-rights date by an amount proportional to the discount provided, making the ‘cheap’ entry point mathematically neutral for existing holders. The actual benefit depends entirely on whether the firm deploys the newly raised capital into projects that generate returns above their hurdle rate, not the discount itself.

Check Your Understanding

Practice Question 1

Company XYZ announces a rights issue in the ratio of 1:5 at a price of Rs 100, while the prevailing market price is Rs 150. If an existing shareholder decides neither to subscribe to the shares nor to sell their Rights Entitlements (REs) in the market, what is the immediate impact?

Practice Question 2

Which of the following best describes the purpose of Rights Entitlements (REs) being tradeable in the Indian market?

This is a companion read for Section 6.1 — Nature and Definition of Primary Markets from PASS Investment Adviser (Level 1) by Akhilesh Gururani, available on Amazon Kindle.

Copyright © 2026 HABSG Consulting